Neopharm
KOSDAQ · Consumer Defensive · ₩342B
₩21,600+1.17%
Price
17,230원
21,600원
Jun 15, 26Sep 11, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue₩40.6B-6.8%
Operating Income₩8.8B-10.1%
Net Income₩7.3B-13.1%
6/'26 vs prev quarter
Company Health
Market Cap₩342B
Operating Margin+21.9%
Cash on Hand1,452억원42.4% of market cap
Free Cash Flow197억원5.7% of market cap
Short Volume 2.1% · as of 26.09.11
Among 27 화장품 peers
LowMedianHigh
PSR2.3xmedian 1.1xPER11.2xmedian 10.8xPBR1.7xmedian 1.4xROE+15.3%median +11.5%
